Ordering
Available Variants10 mg
CHA.73567-10mg
Price
€380.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.73567-10mg | €380.00 |
phyproof® Reference Substance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C22H28N2O4 |
|---|---|
| CAS Number | 17391-18-3 |
| Molecular Weight | 384.47 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| MDL number | MFCD22124999 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H300 |
| pcodes | P264 - P270 - P301 + P310 + P330 - P405 - P501 |
| Hazard Classifications | Acute Tox. 2 Oral |
| Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Corynoxine B, with the chemical formula C18H23NO4 and CAS number 17391-18-3, is a naturally occurring compound that has garnered significant attention in the scientific community due to its unique pharmacological properties. It is an alkaloid derived from the roots of the Uncaria rhynchophylla plant, which has been used in traditional medicine for centuries. Research has shown that Corynoxine B exhibits a range of biological activities, including neuroprotective, anti-inflammatory, and antioxidant effects. Its potential therapeutic applications include the treatment of neurodegenerative diseases, such as Alzheimers and Parkinsons, as well as other conditions characterized by oxidative stress and inflammation. Further studies are needed to fully elucidate the mechanisms of action and potential clinical uses of Corynoxine B, but its natural origin and promising pharmacological profile make it an attractive candidate for drug development and research.
